Upgrade to SI Premium - Free Trial

Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

November 7, 2024 4:38 PM

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11). Revenue for the quarter came in at $9.09 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

Categories

Earnings

Next Articles